Avantax Advisory Services Inc. Sells 5,756 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Avantax Advisory Services Inc. lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 11.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 43,544 shares of the pharmacy operator’s stock after selling 5,756 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Walgreens Boots Alliance were worth $1,137,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in WBA. Dark Forest Capital Management LP boosted its stake in Walgreens Boots Alliance by 6.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 1,804 shares during the period. New York Life Investment Management LLC boosted its position in shares of Walgreens Boots Alliance by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 115,196 shares of the pharmacy operator’s stock worth $3,008,000 after buying an additional 690 shares during the period. Deutsche Bank AG grew its holdings in shares of Walgreens Boots Alliance by 36.2% during the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock worth $48,269,000 after buying an additional 576,534 shares in the last quarter. Van ECK Associates Corp raised its position in Walgreens Boots Alliance by 28.2% in the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock valued at $2,873,000 after buying an additional 28,400 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after buying an additional 10,962,030 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Finally, Truist Financial reiterated a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $24.36.

View Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Down 0.9 %

Shares of Walgreens Boots Alliance stock opened at $18.18 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The business has a fifty day simple moving average of $18.91 and a two-hundred day simple moving average of $21.33. Walgreens Boots Alliance, Inc. has a 1 year low of $17.12 and a 1 year high of $32.89. The company has a market capitalization of $15.68 billion, a price-to-earnings ratio of -2.60, a P/E/G ratio of 1.13 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period in the prior year, the firm earned $1.16 earnings per share. The company’s revenue was up 6.3% on a year-over-year basis. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.50%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.29%.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Manmohan Mahajan bought 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.